Skip to content
Politically.com Search all
Menu

2026 · 1st Quarter (Jan 1 - Mar 31)

VIATRIS INC

Filed by VIATRIS INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 21, 2026
Income
Not reported
Expenses
$490,000.00
Registrant
VIATRIS INC.
Filing UUID
d9004eff-36db-4dd3-aedd-f02b5f3a0827
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

S. 891, the Bipartisan Health Care Act Part D Formulary Design and Generic Drug Tiering H.R. 1843 / S. 1302 - Increasing Transparency in Generic Drug Applications Act HR 4132 / S.2027 - Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act Drug Shortages S.2658 - The Medication Affordability and Patent Integrity Act

Literal federal measure citations: S. 891, H.R. 1843, S. 1302, HR 4132, S.2027, S.2658

CPT · Copyright/Patent/Trademark

IP Issues related to generic medicines Patent Settlements S 1553, The PREVAIL Act

Literal federal measure citations: S 1553

TRD · Trade (domestic/foreign)

Trade issues related to generic medicines Pharmaceutical supply chain S.3778: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act S.3841: Last Sale Valuation Act

Literal federal measure citations: S.3778, S.3841

FIN · Financial Institutions/Investments/Securities

Policy related to corporate governance

DEF · Defense

S.2296 National Defense Authorization Act

Literal federal measure citations: S.2296

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.